Raphael Pharmaceutical Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Raphael Pharmaceutical Inc. (RAPH) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$44.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-14
- Raphael Pharmaceutical Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$44.00K, a 241.94% decline year-over-year.
- Raphael Pharmaceutical Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $31.00K, a 45.61% decline year-over-year.
- Raphael Pharmaceutical Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was $57.00K.
- Raphael Pharmaceutical Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was $26.00K.
- Raphael Pharmaceutical Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$211.00K.
- Raphael Pharmaceutical Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$58.00K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$44.00K 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | -$44.00K 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | $26.00K 10-K · filed 2026-03-31 | |||
| 2025-09-30 | -$16.00K 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $1.00K 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | $31.00K 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | -$211.00K 10-K · filed 2026-03-31 | |||
| 2024-09-30 | -$190.00K 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | -$110.00K 10-Q · filed 2025-08-13 | |||
| 2024-03-31 | $57.00K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | -$58.00K 10-K · filed 2025-03-31 |